282.000
−2,69%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -5.0% | +4.8% | 2 / 3 | -1.3% | -3.11 pp | -1.91 pp | +28.0% | 0.00 | 10.23 | 42,9 | −1,3% | 21,2 | −5,0% | 10.23 | 11.28 | −9,3% |
| Pts | 0 | 0 | 8 | 0 | 0 | 4 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 282.000 (close price on 2026-10-19)EPS (TTM): 27.569
Financial charts
1.Revenue & growth
VND bn42,9Q2/26
1.Revenue & growth
VND bn42,9Q2/26
2.Profit & growth
VND bn21,2Q2/26
3.Profit mix (Penman)
VND bn104Q2/26
4.Margins & cost structure
%58.9%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn38,5Q2/26
7.Asset structure
VND bn354Q2/26
8.Funding & debt health
VND bn · times354Q2/26
9.Revenue backlog
VND bn0,28Q2/26
10.Valuation
times · %10,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %7.066Q2/26
Adjusted EPS growth, latest quarter
-5.0%
Average adjusted EPS growth, 3 quarters
4.8%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26